Genomics Sequencing

About Genomics Sequencing

Genome sequencing refers to the process of determining the sequence of a cells genetic code.

Over the last decade, advances in next generation sequencing technologies has enabled significant progress in our understanding of the biology of cancer cells. By comparing the differences between the genetic sequence of cancerous and normal cells, we can better understand the biological pathways associated with cancer onset and progression and this information can be used to further improve, or develop new treatment strategies. NCARD currently has a number of projects that involve genomic sequencing and analyses; which are listed below.

Identification and validation of biomarkers for mesothelioma
Molecular mechanisms of response and resistance to immunotherapy in mesothelioma
Targeted epigenetic modification to improve mesothelioma responses to immunotherapy
The integration of mathematics and TCR sequencing to understand how an individual’s immune system contributes to therapy success
Using gene expression to predict successful responses to chemoimmunotherapy
Menu